Pharmaceutical industry has withdrawn from the ‘antibiotic space.’ Is it time for research universities to step in? The Centers for Disease Control and Prevention has said that at least 2 mi... Read more
There is clearly something wrong with pharmaceutical innovation. Antibiotic-resistant infections sicken more than two million Americans every year and kill at least 23,000. The World Health... Read more
Imagine having tiny electronics implanted somewhere in your body that can regulate nerve signals and make symptoms of various disorders go away. That’s the vision of the field of bioelectron... Read more
A small study at Boston Children’s Hospital may lead to a breakthrough treatment for kids with life-threatening peanut allergies. Researchers there combined an FDA-approved allergy drug, Xol... Read more
The experimental cancer drug ibrutinib has wowed in clinical trials, beating deadly blood cancers without the painful side effects of currently approved therapies. And it has raced through d... Read more
The future of biomedical innovation depends in part on a new trend for all players in biomedical innovation to work together for the common goal, say 2 MIT researchers It’s a long, exp... Read more
Serious side effects are the main reason why existing drugs must be removed from the market Side effects are a major reason that drugs are taken off the market and a major reason why... Read more
The fourth-leading cause of death in the U.S. Side effects are a major reason that drugs are taken off the market and a major reason why patients stop taking their medications, but scientist... Read more
Safe, Multi-functional Anti-inflammatory/Anti-allergic Drugs Developed by Hebrew University Research
A synthetic, anti-inflammatory and anti-allergic family of drugs to combat a variety of illnesses, while avoiding detrimental side effects, has been developed by a Hebrew University of Jerus... Read more
Researchers say pharmaceutical ‘innovation crisis’ is a myth Two professors, including one from the Philadelphia area, wrote this week in the British Medical Journal that cries f... Read more
Prices were on average more than two-and-a-half times cheaper than the US. Drug makers could pull out of research in Britain because the Government is too focused on rewarding “breakth... Read more
Products from genetically modified crops can be identified at low concentration It is important to be able to monitor genetically modified (GM) crops, not only in the field but also during t... Read more
Covers such key areas as prostate cancer, schizophrenia, diabetes and Alzheimer’s Drugs giant AstraZeneca is to share 22 of its early-... Read more
(Part I of III) Healthcare’s hyperinflation is driving the transformation of how care gets reimbursed resulting in a massive disruption in healthcare. For example, pharma companies will succ... Read more
Image via Wikipedia Research, in any field of science, is not the risk-free business that might easily be supposed from the confident promises of scientific spokesmen or the daily reports of... Read more
